Mitochondrial alterations near amyloid plaques in an Alzheimer'S disease mouse model

Journal of Neuroscience

Volumn 33, Issue 43, 2013, Pages 17042-17051

  Xie, Hong ^a,b   Guan, JiSong ^b   Borrelli, Laura A ^a   Xu, Jing ^b   Serrano Pozo, Alberto ^a   Bacskai, Brian J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FLUORESCENCE IMAGING; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NERVE CELL NETWORK; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NEURITES; OXIDATIVE STRESS; PLAQUE, AMYLOID;

EID: 84886925692     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1836-13.2013     Document Type: Article

References (46)

1. Abramov A.Y., Canevari L, Duchen MR (2004) Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24: 565-575. CrossRef Medline
2. Ankarcrona M., Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973. CrossRef Medline
3. Borchelt D.R., Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland N.G., Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939-945. CrossRef Medline
4. Calkins M.J., Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 20:4515-4529. CrossRef Medline
5. Calkins M.J., Manczak M, Reddy PH (2012) Mitochondria-targeted antioxidant SS31 prevents amyloid beta-induced mitochondrial abnormalities and synaptic degeneration in Alzheimer's disease. Pharmaceuticals 5:1103-1119. CrossRef Medline
6. Cannon M.B., Remington SJ (2008) Redox-sensitive green fluorescent protein: probes for dynamic intracellular redox responses. Areview. Methods Mol Biol 476:51-65. Medline
7. Chan D.C. (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241-1252. CrossRef Medline
8. Cras P., Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A 88:7552-7556. CrossRef Medline
9. Dikranian K., Kim J, Stewart FR, Levy MA, Holtzman DM (2012) Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Int J Clin Exp Pathol 5:482-495. Medline
10. Dooley C.T., Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY (2004) Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem 279:22284-22293. CrossRef Medline
11. Eckert G.P., Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE (2012) Mitochondrial dysfunction-a pharmacological target in Alzheimer's disease. Mol Neurobiol 46:136-150. CrossRef Medline
12. Fukui H., Moraes CT (2008) The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 31:251-256. CrossRef Medline
13. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S., Prada C, Greenberg SM, Bacskai BJ, Frosch MP (2006) Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516-524. CrossRef Medline
14. Gauthier S., Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367:1262-1270. CrossRef Medline
15. Gibson G.E., Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm 105:855-870. CrossRef Medline
16. Hirai K., Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris P.L., Jones PK, Petersen RB, Perry G, SmithMA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023. Medline
17. Johnson L.V., Walsh ML, Bockus BJ, Chen LB (1981) Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 88:526-535. CrossRef Medline
18. Keller J.N., Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP (1997) Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284. Medline
19. Knott A.B., Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mito-chondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505-518. CrossRef Medline
20. Koffie R.M., Meyer-Luehmann M, Hashimoto T, Adams KW, Mielke ML, Garcia-Alloza M, Micheva KD, Smith SJ, Kim ML, Lee VM, Hyman BT, Spires-Jones TL (2009) Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 106:4012-4017. CrossRef Medline
21. Kuchibhotla K.V., Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59:214-225. CrossRef Medline
22. Kurt M.A., Davies DC, Kidd M, Duff K, Rolph SC, Jennings KH, Howlett DR (2001) Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp Neurol 171:59-71. CrossRef Medline
23. Lustbader J.W., Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X., Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker D.G., Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, et al. (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-452. CrossRef Medline
24. Manczak M., Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15:1437-1449. CrossRef Medline
25. Manczak M., Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 20:2495-2509. CrossRef Medline
26. Mattson M.P., Partin J, Begley JG (1998) Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Res 807:167-176. CrossRef Medline
27. Mattson M.P., Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60:748-766. CrossRef Medline
28. Maurer I., Zierz S, Möller HJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21:455-462. CrossRef Medline
29. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman B.T. (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 451:720-724. CrossRef Medline
30. Moreira P.I., Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, PerryG (2007) Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3:614-615. Medline
31. Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486-510. CrossRef Medline
32. Nicholls D.G. (2012) Fluorescence measurement of mitochondrial membrane potential changes in cultured cells. Methods Mol Biol 810:119-133. CrossRef Medline
33. ParkerWDJr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40:1302-1303. CrossRef Medline
34. Pendergrass W., Wolf N, PootM (2004) Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues. Cytometry A 61:162-169. Medline
35. Pérez-Gracia E, Torrejón-Escribano B, Ferrer I (2008) Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol 116:261-268. CrossRef Medline
36. Perry S.W., Norman JP, Barbieri J, Brown EB, GelbardHA (2011) Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50:98-115. CrossRef Medline
37. Reddy P.H. (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease. Exp Neurol 218:286-292. CrossRef Medline
38. Reddy P.H., Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb U.P., Calkins MJ, Reddy AP, Mao P, ManczakM 2012 Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta 1822:639-649. CrossRef Medline
39. Reers M., Smith TW, Chen LB (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30:4480-4486. CrossRef Medline
40. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW (2004) Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122:131-139. CrossRef Medline
41. Smith M.A., Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382:120-121. CrossRef Medline
42. Spires T.L., Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai B.J., Hyman BT (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25:7278-7287. CrossRef Medline
43. Tsai J., Grutzendler J, Duff K, Gan WB (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7:1181-1183. CrossRef Medline
44. Wang X., Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105:19318-19323. CrossRef Medline
45. Wang X., Su B, Zheng L, Perry G, Smith MA, Zhu X (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 109 [Suppl 1]:153-159. CrossRef Medline
46. Xie H., Hou S, Jiang J, Sekutowicz M, Kelly J, Bacskai BJ (2013) Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc Natl Acad Sci U S A 110:7904-7909. CrossRef Medline